P.115 Human Leukocyte Antigen Distribution Among Kidney Transplant Donors and Recipients: Data
from Central Indian Region
Dr. Sunny Malde, India
P.116 Kidney Transplantation in Patients with Complement Gene Mutations: A Single-Centre Experience from Central India
Dr. Pranjal Kashiv, India
P.117 Profile of Tuberculosis in Kidney Transplant Recipients: A Single Centre Experience from Central India
Dr. Shubham Dubey, India
P.119 Kidney Transplantation Using Renal Grafts From A DCD Donor Who Had Previously Received A Bilateral Lung Transplant
Jeffrey P Orlowski, United States
P.120 Dynamic trends in deceased donor kidney utilization: Unraveling discard rates and KDPI shifts across pre-COVID, COVID, and post-COVID eras
Jeffrey P Orlowski, United States
P.121 To evaluate the outcomes of right sided laparoscopic donor nephrectomy in Pakistani kidney donors
Dr. Abdul Khalique, Pakistan
P.122 The outcomes of renal transplantation during the covid-19 pandemic. Is it worth doing?
Dr. Abdul Khalique, Pakistan
P.124 COVID-19 Positive Kidney Transplant Recipients behave differently compared to non-transplant patients’ ICU: single center experience.
Dr. Osama Gheith, Egypt
P.125 Add-on Extracorporeal Membrane Oxygenation in critically ill COVID-19 positive patients: risk factors and predictors of survival.
Dr. Osama Gheith, Egypt
P.126 Recurrence of AA amyloidosis in kidney transplant recipients
Dr. Aygul Celtik, Turkey
P.127 Covid-19 infection in a large cohort of kidney transplant recipients from a single center
Dr. Aygul Celtik, Turkey
P.131 A nationwide report of long term covid-19 sequalae in kidney transplant recipients: Largest report from India
Dr. Sudeep Desai, India
P.132 Immune Response after 2 doses of Vaccine against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS Cov-2) Infection among Patients of Renal Transplantation
Dr. MD Masud Iqbal, Bangladesh
P.133 Identification of risk of malaria and selective post-transplant testing of deceased organ donors in the UK
Ines Ushiro-Lumb, United Kingdom
P.134 Assessment Of Tacrolimus-Based Vs. Cyclosporine-Based Maintenance Immunosuppressive Regimens Among Living Donor Kidney Transplant Recipients With Low Immunological Risk: Single Centre Experience.
Dr. Osama Gheith, Egypt
P.135 Comparison between Tacrolimus-based and cyclosporine-based maintenance immunosuppressive regimens in kidney transplant recipients with functioning grafts beyond 15 years
Dr. Osama Gheith, Egypt
P.136 Heart transplantation following medically assisted dying using ex situ normothermic machine perfusion
Dr. Michael J O'Leary, Australia
P.137 Which immunodeficiency status has greater risks of poor pneumocystic pneumonia outcomes than other immunocompromised populations?
Dr. Poramed Winichakoon, Canada
P.139 Covid-19 infection outcomes of the kidney transplant recipients in Mongolia
Dr. Khishgee Tseren, Mongolia
P.140 Urinary tract infection graft outcomes in kidney transplanted patient in Mongolia
Dr. Khishgee Tseren, Mongolia
P.141 Renal vascular disparities among kidney donors, a reterospective study
Dr. Muhammad Tassaduq Khan, Pakistan
P.142 Frequency of urinary tract infection by multi-drug resistance organisms and its effect on graft function in renal transplant recipients
Dr. Muhammad Tassaduq Khan, Pakistan
P.143 Diabetes mellitus as a risk factor for urinary tract infections in kidney transplant recipients
Prof. Nada Kanaan, Belgium
P.144 Is not treating ≤3000 IU /ml of Cytomegalovirus viremia safe in living donor R+D+ renal transplant recipients?
Dr. Sunil Kumar Dodani, Pakistan
P.145 Mortality risk factors and survival outcomes of patients on the kidney transplant waiting list in Tunisia
Prof. Mohamed Mongi Bacha, Tunisia
P.146 Access to kidney transplantation for patients on the deceased donor waiting list in Tunisia: a single-center study
Prof. Mohamed Mongi Bacha, Tunisia
P.147 Impact of the 2011 Tunisian revolution on kidney transplantation accessibility from waiting list: a single center study
Prof. Mohamed Mongi Bacha, Tunisia
P.150 Viral infections in pediatric kidney transplant recipients: Impact on graft function, risk factors, and patient outcomes
Prof. Esra Baskin, Turkey
P.151 Multinational, retrospective study assessing treatment patterns, outcomes, and healthcare resource utilization in solid organ transplant recipients with cytomegalovirus infection and intolerance to anti-cytomegalovirus treatments
Mrs. Kimberly H Davis, United States
P.152 Respiratory multiplex PCR could predict morbidity and mortality in solid organ transplant patients